Back to search
FDAFDA · Food and drugs·Recall number D-0963-2022

Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-902-05

Published June 8, 2022 · Recall initiated: May 18, 2022

Summary

FDA records drug Class II recall D-0963-2022, published June 8, 2022 and initiated May 18, 2022. Recalling firm: Nephron Sterile Compounding Center LLC; Status: Terminated; Reported quantity: 64450 syringes; Lot: Lots: NE2001A, Exp. 6/30/2022; NE2009B, Exp. 8/27/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Sterile Compounding Center LLC
Distributor
Nationwide in the USA
Lot
Lots: NE2001A, Exp. 6/30/2022; NE2009B, Exp. 8/27/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-902-05 recalled?

Yes. FDA published recall D-0963-2022 on June 8, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter